(Q76385024)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

title

[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

author name string

Sergio Reus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Joaquín Portilla

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Adelina Gimeno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

José Sánchez-Payá

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

J A García-Henarejos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Onofre Martínez-Madrid

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Jordi Usó

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

Bernardino Roca

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

María José Galindo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

José López-Aldeguer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

Infectious Diseases and Clinical Microbiology

24 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

142-149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/microL.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Factors associated with survival in human immunodeficiency virus-infected patients with very low CD4 counts

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

CD4 Count and the Risk for Death in Patients Infected with HIV Receiving Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Usefulness of the Cytomegalovirus (CMV) Antigenemia Assay for Predicting the Occurrence of CMV Disease and Death in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Natural history of HIV infection in the era of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Causes of death in persons with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Impact of HAART on causes of death of persons with late-stage AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Survival after a very low (< 5 × 106/l) CD4+ T-cell count in individuals infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Long-term survival in patients with advanced immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Workin

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2804%2973054-2

7 January 2021

10.1016/S0213-005X(04)73054-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14987534%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference